JFM brought this important point of view to my
JFM brought this important point of view to my attention
“IMO shows confidence in what he has done with B with K and now everyone waits for results...
But PRs indicates that he is clearly not "all eggs in one basket"...
OM (Phase III) and
UP (Phase IIb) appear to be well to Clinical Trials
UC formulation...PR'd
...IMO he allocates limited dollars prudently...for multiple opportunities”
1. Kevetrin: Oncology Reports, a leading oncology journal, supporting the therapeutic potential of Kevetrin, the Company’s p53-modulating anti-cancer drug candidate, in treating Acute Myeloid Leukemia (AML). AML accounts for approximately one-quarter to one-third of all leukemias worldwide and has a 5-year survival rate of only 24 percent.
2. OM: The Company had previously engaged Locust Walk to assess the value of its clinical assets, which included recently an in-depth assessment of the commercial opportunity of oral rinse Brilacidin-OM—a Phase 3-ready, FDA Fast Track-designated clinical asset in late-stage development targeting a substantial untapped market in supportive cancer care. This renewed engagement is a continuation of Innovation Pharmaceutical’s business relationship with Locust Walk toward realizing the market potential of the Company’s pipeline.
3. Innovation Pharmaceuticals Completes Final Patient Visit in Phase 2b Study of Oral Prurisol for Psoriasis … visits have been completed in its Phase 2b clinical study of oral Prurisol in moderate-to-severe chronic
4. Cellceutix Selects Dr. Reddy’s Laboratories for Formulation of Brilacidin for Opthalmic and Otitis Infections
Cellceutix Selects Dr. Reddy’s Laboratories for Formulation of Brilacidin for Opthalmic and Otitis Infections … , custom pharmaceutical services, generics, biosimilars, differentiated formulations and NCEs … , announces today that the Company has concluded negotiations with formulation developers and selected … as OctoPlus specializes in complex formulations. We are extremely optimistic about Brilacidin for … Exchange-listed company traded under the ticker “RDY”, for the formulation of the Company’s defensin … expertise in both APIs and formulation development will assist Cellceutix in the clinical
Now IMO as for Leo? He B BIZZY BOY. I like him. Lol
6
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Ronald A Phillips
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Facing the Realities of Aging In Place Alright, let's talk straight. Everyone dreams of staying home in their twilight years, kicking back in their favorite chair with family nearby. But the harsh truth? That comfort comes with a price tag. According to Northwestern Mutual's 2026 Planning & Progress Study, up to 83% of Boomers+ and most other generations fancy the idea of...
Continue Reading
An Unexpected Wave of Enthusiasm in Event Industry The Event Industry Power 50 is getting some serious action this year. Over 3,500 votes have already rolled in, smashing last year's numbers with days still left on the clock. It seems like folks can't wait to see their favorite event powerhouses crowned at this year's gala, which kicks off October 27 in New York City....
Continue Reading
Investment Gold in Abilene's Storage Sector Diving headfirst into the world of bricks and mortar, the opportunity brewing over in Abilene, Texas, packs a potent punch for anyone keen on beefing up their real estate portfolio with a top-notch asset. We're talking about Spare Feet Self Storage, a slick, Class A self-storage facility, serving the cream of the crop in a...
Continue Reading
An Automotive Feat in R&D Now here's a story that should make waves across the automotive sector. China Automotive Systems, Inc. (NASDAQ: CAAS), a titan of power steering development in China, has nailed it by meeting the ASPICE 4.0 Capability Level 2. That's a big one, folks. Verified by a partnership between a European automaker and UL, this achievement is no fluke....
Continue Reading
Ah, the pharmaceutical game is shifting again, and this time Celltrion USA's putting their chips down with OMLYCLO, the shiny new omalizumab biosimilar. Here we see a product that's not just approved but interchangeable with XOLAIR, making it a front-runner in the allergic and inflammatory conditions battleground. If you're a patient or a provider navigating these murky...
Continue Reading
Co-op Living: Not All It's Cracked Up to Be Let me tell you something, buying a co-op in New York City isn't just signing on the dotted line and moving in. Nope, it's a whole damn production. Jeff Namian's book, Thin Walls/Thick Ears, lays it all out with a mix of humor and hard truths, painting a stark picture of NYC co-op living. He's not just telling his own story of...
Continue Reading
A New Era for Pickleball in Palm Beach It might be time to re-evaluate pickleball if you weren't paying attention before. The Palm Beach Royals have wrapped up their first Major League Pickleball season with a bang, marking a pivotal year for the sport. This underdog tale of graft and grit is carving out a new chapter in the world of sport. Record-Breaking Season for MLP...
Continue Reading
TRIMAX's Bold Move into AI-Powered Infrastructure It feels like we're standing on the cusp of a seismic shift, folks. Artificial intelligence isn't just another buzzword anymore—it's a juggernaut reshaping our digital world. TRIMAX Power Systems is gearing up to ride this wave, with its eyes set on capturing a chunk of the booming demand for fast-deployable power...
Continue Reading
From Ashes to Airwaves Gritty stories of survival often cut deeper than any wonky industry analysis or corporate earnings report. When you've been through the wringer and come out the other side, that experience sticks with you—and for Kim S. Marshall, it ignited something personal yet universal with the #L.A. Rising podcast. Emerging from the 2025 L.A. fires, this...
Continue Reading
Indiana American Water Dishes Out Big Buck Refunds Swing by Indiana American Water's latest move, and what do you see? A whopping $25.5 million in PFAS settlement credits being doled out to customers. That's right, this ain't your everyday water utility story—there's real money on the line here. Over four rounds of bill credits since November 2025, customers have seen...
Continue Reading
Top 5 Most Recently Viewed Articles
Anticipating Vertiv Hldgs's Earnings Release Vertiv Hldgs (VRT) is gearing up to announce its quarterly earnings soon. As the date approaches, investors are eager to understand the expectations and implications of this release. Analysts predict an earnings per share (EPS) of $0.69, setting the stage for potential market movement. When companies like Vertiv prepare to...
Continue Reading
Navigating Construction Loans with Confidence License #458038 Embarking on a significant home remodeling or custom-building project can be challenging, especially when it comes to financing. This guide from Murray Lampert Design, Build, Remodel aims to streamline the process, helping you secure a construction loan efficiently. Understanding what to present to your lender,...
Continue Reading
FirstEnergy Corp. Declares Quarterly Dividend The Board of Directors of FirstEnergy Corp. (NYSE: FE) has declared a significant quarterly dividend of 44.5 cents per share on its outstanding common stock. This decision reflects the company's ongoing commitment to delivering value to its shareholders. The dividend is scheduled to be paid to shareholders of record on a...
Continue Reading
Conavi Medical Corp. Plans Major Public Offering Conavi Medical Corp. (TSXV: CNVI) is making headlines with its announcement of a new public offering. As a pioneering medical device company, Conavi specializes in imaging technologies designed for minimally invasive cardiovascular procedures. The recent announcement is a strategic step to enhance their growth trajectory...
Continue Reading
PreSnap Picks: The New Face of NFL Game Analysis Empowering NFL Fans with Unmatched Insights RoadMap Technologies, known for its innovative predictive analytics solutions, is stepping into the world of sports with its latest offering, the PreSnap Picks app. This iPhone application is designed to provide NFL enthusiasts a significant advantage in understanding and...
Continue Reading